rs150574055

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003334.4(UBA1):​c.1702C>G​(p.Leu568Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00351 in 1,203,705 control chromosomes in the GnomAD database, including 55 homozygotes. There are 1,397 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0041 ( 4 hom., 172 hem., cov: 24)
Exomes 𝑓: 0.0035 ( 51 hom. 1225 hem. )

Consequence

UBA1
NM_003334.4 missense

Scores

7
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 2.09

Publications

8 publications found
Variant links:
Genes affected
UBA1 (HGNC:12469): (ubiquitin like modifier activating enzyme 1) The protein encoded by this gene catalyzes the first step in ubiquitin conjugation to mark cellular proteins for degradation. This gene complements an X-linked mouse temperature-sensitive defect in DNA synthesis, and thus may function in DNA repair. It is part of a gene cluster on chromosome Xp11.23. Alternatively spliced transcript variants that encode the same protein have been described. [provided by RefSeq, Jul 2008]
INE1 (HGNC:6060): (inactivation escape 1) X chromosome inactivation provides dosage compensation for the expression level of X-linked genes from the single X in males and the two in females. This X chromosome gene is intronless and was identified because its transcription escapes X inactivation in females. This gene does not make a protein.[provided by RefSeq, May 2010]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_003334.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008150339).
BP6
Variant X-47206074-C-G is Benign according to our data. Variant chrX-47206074-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 368339.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0608 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003334.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
UBA1
NM_003334.4
MANE Select
c.1702C>Gp.Leu568Val
missense
Exon 15 of 26NP_003325.2
UBA1
NM_001440807.1
c.1744C>Gp.Leu582Val
missense
Exon 16 of 27NP_001427736.1
UBA1
NM_001440809.1
c.1720C>Gp.Leu574Val
missense
Exon 16 of 27NP_001427738.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
UBA1
ENST00000335972.11
TSL:1 MANE Select
c.1702C>Gp.Leu568Val
missense
Exon 15 of 26ENSP00000338413.6P22314-1
UBA1
ENST00000377351.8
TSL:1
c.1702C>Gp.Leu568Val
missense
Exon 15 of 26ENSP00000366568.4P22314-1
UBA1
ENST00000880189.1
c.1837C>Gp.Leu613Val
missense
Exon 16 of 27ENSP00000550248.1

Frequencies

GnomAD3 genomes
AF:
0.00410
AC:
458
AN:
111825
Hom.:
4
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.000325
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000188
Gnomad ASJ
AF:
0.0106
Gnomad EAS
AF:
0.0556
Gnomad SAS
AF:
0.00417
Gnomad FIN
AF:
0.0253
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000941
Gnomad OTH
AF:
0.00403
GnomAD2 exomes
AF:
0.00782
AC:
1306
AN:
167034
AF XY:
0.00702
show subpopulations
Gnomad AFR exome
AF:
0.000167
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00700
Gnomad EAS exome
AF:
0.0548
Gnomad FIN exome
AF:
0.0240
Gnomad NFE exome
AF:
0.00146
Gnomad OTH exome
AF:
0.00878
GnomAD4 exome
AF:
0.00345
AC:
3772
AN:
1091826
Hom.:
51
Cov.:
31
AF XY:
0.00342
AC XY:
1225
AN XY:
358234
show subpopulations
African (AFR)
AF:
0.0000761
AC:
2
AN:
26282
American (AMR)
AF:
0.0000290
AC:
1
AN:
34541
Ashkenazi Jewish (ASJ)
AF:
0.00684
AC:
132
AN:
19305
East Asian (EAS)
AF:
0.0632
AC:
1890
AN:
29919
South Asian (SAS)
AF:
0.00318
AC:
168
AN:
52909
European-Finnish (FIN)
AF:
0.0239
AC:
956
AN:
40076
Middle Eastern (MID)
AF:
0.000726
AC:
3
AN:
4134
European-Non Finnish (NFE)
AF:
0.000484
AC:
406
AN:
838824
Other (OTH)
AF:
0.00467
AC:
214
AN:
45836
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
190
381
571
762
952
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00408
AC:
456
AN:
111879
Hom.:
4
Cov.:
24
AF XY:
0.00505
AC XY:
172
AN XY:
34075
show subpopulations
African (AFR)
AF:
0.000325
AC:
10
AN:
30811
American (AMR)
AF:
0.000188
AC:
2
AN:
10629
Ashkenazi Jewish (ASJ)
AF:
0.0106
AC:
28
AN:
2650
East Asian (EAS)
AF:
0.0553
AC:
195
AN:
3529
South Asian (SAS)
AF:
0.00418
AC:
11
AN:
2631
European-Finnish (FIN)
AF:
0.0253
AC:
154
AN:
6097
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.000941
AC:
50
AN:
53121
Other (OTH)
AF:
0.00398
AC:
6
AN:
1508
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
17
35
52
70
87
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00324
Hom.:
80
Bravo
AF:
0.00297

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
Infantile-onset X-linked spinal muscular atrophy (2)
-
-
1
Infantile-onset X-linked spinal muscular atrophy;C5435753:VEXAS syndrome (1)
-
-
1
not provided (1)
-
-
1
UBA1-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.17
CADD
Benign
17
DANN
Uncertain
1.0
DEOGEN2
Benign
0.36
T
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.78
T
MetaRNN
Benign
0.0082
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
1.8
L
PhyloP100
2.1
PrimateAI
Uncertain
0.59
T
PROVEAN
Uncertain
-2.6
D
REVEL
Uncertain
0.39
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.040
D
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.91
gMVP
0.94
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs150574055;
hg19: chrX-47065473;
COSMIC: COSV60111495;
COSMIC: COSV60111495;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.